COST-EFFECTIVENESS OF GUANFACINE EXTENDED-RELEASE AS AN ADJUNCTIVE THERAPY TO A LONG-ACTING STIMULANT VERSUS LONG-ACTING STIMULANT MONOTHERAPY FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN CANADA

被引：0
|
作者：
Lachaine, J. [1 ]
Sikirica, V [2 ]
Mathurin, K. [1 ]
机构：
[1] Univ Montreal, Montreal, PQ, Canada
[2] Shire Dev LLC, Wayne, PA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1251
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH32
引用
收藏
页码：A214 / A214
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF LONG-ACTING OLANZAPINE VERSUS LONG-ACTING RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA IN SPAIN
    Dilla, T.
    O'Donohoe, P.
    Moeller, J.
    Alvarez, M.
    Sacristan, J.
    San, L.
    Happich, M.
    Tockhorn, A.
    VALUE IN HEALTH, 2011, 14 (07) : A292 - A292
  • [22] Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
    Tatiana Dilla
    Jörgen Möller
    Paul O’Donohoe
    María Álvarez
    José A Sacristán
    Michael Happich
    Antje Tockhorn
    BMC Psychiatry, 14
  • [23] The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials
    Jose Cerrillo-Urbina, Alberto
    Garcia-Hermoso, Antonio
    Jesus Pardo-Guijarro, Maria
    Sanchez-Lopez, Mairena
    Luis Santos-Gomez, Jose
    Martinez-Vizcaino, Vicente
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (08) : 494 - 507
  • [24] Sex Differences in Effectiveness of Extended-Release Stimulant Medication among Adolescents with Attention-Deficit/Hyperactivity Disorder
    Amori Yee Mikami
    Daniel J. Cox
    Margaret T. Davis
    H. Kent Wilson
    R. Lawrence Merkel
    Roger Burket
    Journal of Clinical Psychology in Medical Settings, 2009, 16 : 233 - 242
  • [25] Sex Differences in Effectiveness of Extended-Release Stimulant Medication among Adolescents with Attention-Deficit/Hyperactivity Disorder
    Mikami, Amori Yee
    Cox, Daniel J.
    Davis, Margaret T.
    Wilson, H. Kent
    Merkel, R. Lawrence
    Burket, Roger
    JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS, 2009, 16 (03) : 233 - 242
  • [26] Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior stimulant treatment
    Huss, M.
    Hervas, A.
    Dirks, B.
    Bliss, C.
    Prochazka, J.
    Cutler, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S737 - S737
  • [27] Predictors of treatment outcome with long-acting methylphenidate in attention deficit hyperactivity disorder in adults
    Ramos-Quiroga, J. A.
    Kooij, S.
    Trott, G. E.
    Medori, J. R.
    Dejonckheere, J.
    van Oene, J. C.
    Schaeuble, B.
    Casas, M.
    Buitelaar, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S352 - S353
  • [28] Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder
    Sinzig, Judith
    Doepfner, Manfred
    Lehmkuhl, G.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (04) : 421 - 432
  • [29] Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder
    Sayer, Gregory R.
    McGough, James J.
    Levitt, Jennifer
    Cowen, Jennifer
    Sturm, Alexandra
    Castelo, Edward
    McCracken, James T.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (10) : 882 - 888
  • [30] Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder (vol 6, pg 381, 2012)
    Erder, M. Haim
    Xie, Jipan
    Signorovitch, James E.
    Chen, Kristina S.
    Hodgkins, Paul
    Lu, Mei
    Wu, Eric Q.
    Sikirica, Vanja
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2013, 11 (03) : 309 - 309
12345